Study Links Ozempic to Lower Stroke and Alzheimer’s Risk
A recent study suggests that Ozempic, a GLP-1 based drug primarily used for weight loss, may also protect the brain by reducing the risk of stroke and Alzheimer’s disease. These findings highlight potential neurological benefits of GLP-1 medications beyond their metabolic effects, opening avenues for further research into dementia prevention.
News Mobile·



